With a goal of increasing the cost-effective and high-throughput genetic marker repertoire in pigeonpea, the following two different sequence resources were surveyed for the presence of SNPs: (i) Illumina GA IIx transcript sequence data and (ii) tentative orthologous genes (TOGs) of closely related legumes.
With potential to increase the cost-effective use of resources and to reduce the lag between diagnosis and start of treatment, ambulatory treatment of drug-susceptible as well as drug-resistant TB can help improve quick and universal access to TB treatment, which in turn mitigates the spread of TB in the population.
The present findings imply that further legislative changes increasing the cost of cigarettes could be effective in helping people quit smoking.
So I'm not sure if the tax, which would then increase the cost, if it would be as effective, possibly as just not having access because that's primarily what this ban is, limiting access to these larger portions.
On the other hand, in case of too many tests, the equipment is not available for animal research for long periods of time, thus increasing the effective cost of the equipment.
The development of drug resistance in bacteria makes antibiotics less effective and increases the costs of therapies.
With the substantial morbidity and mortality associated with COPD [ 2], and the growing proportion of people with COPD, there is an increasing need for cost effective treatment strategies.
But if, as is vitally important, our contribution is to be widely replicated by the thousands who can, the least the government should do is drop its policy of reducing the feed-in tariff; indeed it should increase this cost-effective stimulant.
Therefore, this paper's goal is to provide an insight into the driving forces which have contributed to this outstanding market success, and to investigate how the findings can apply in designing market transformation programmes aimed at increasing the penetration of cost-effective energy-efficient technologies internationally.
Conservative cost-effective ratios might therefore incorrectly impact on the decisions by organizations such as NICE in the UK[ 2], increasing the likelihood of truly cost effective treatments being rejected if predicted/mapped utility values were used.
The documents -- memorandums written in December 2000 by lawyers at Enron to another lawyer at the company -- also describe "dummied-up" power-delivery schedules, the submission of "false information" to the state, and the effective increasing of costs to all market participants by "knowingly increasing the congestion costs".
